🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the safety, tolerability and efficacy of molnup...
Status
Terminated
Location
Kaiser Foundation Hospital - South Bay ( Site 1832)
Start Date
2020-10-19
Trial ID
NCT04575584
Treatments Being Tested
The AGILE platform master protocol allows incorporation of a range of ident...
Status
Recruiting
Location
Desmond Tutu Health Foundation
Start Date
2020-07-03
Trial ID
NCT04746183
The purpose of the study is to assess if the study medication (molnupiravir...
Status
Completed
Location
Cahaba Research, Inc. ( Site 2523)
Start Date
2021-08-11
Trial ID
NCT04939428
Treatments Being Tested
* Research Question: Does convalescent plasma (CCP) collected from donors w...
Status
Terminated
Location
CHU Besançon
Start Date
2022-04-01
Trial ID
NCT05271929
The goal of the study is to learn what happens to MK-4482 after single and ...
Status
Completed
Location
Peking University Third Hospital (Site 0001)
Start Date
2023-06-28
Trial ID
NCT06816030
Treatments Being Tested
The purpose of this study is to evaluate the pharmacokinetics (PK) of N-hyd...
Status
Completed
Location
Research Centers of America ( Hollywood ) ( Site 0002)
Start Date
2022-06-14
Trial ID
NCT05386589
Treatments Being Tested
This study aims to evaluate the safety, tolerability and efficacy of molnup...
Status
Completed
Location
Phoenix Medical Group ( Site 1822)
Start Date
2020-10-19
Trial ID
NCT04575597
Treatments Being Tested
This is a phase 2a double-blind, randomized, placebo-controlled study to ev...
Status
Completed
Location
hVIVO Services ( Site 0001)
Start Date
2023-08-21
Trial ID
NCT05818124
Treatments Being Tested
This is a study of molnupiravir (MK-4482) in healthy participants who have ...
Status
Completed
Location
hVIVO Services ( Site 0001)
Start Date
2022-11-02
Trial ID
NCT05559905
Treatments Being Tested
Researchers are looking for other ways to prevent severe illness from COVID...
Status
Recruiting
Location
Cullman Clinical Trials ( Site 3813)
Start Date
2024-12-02
Trial ID
NCT06667700
Treatments Being Tested